With five products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.
- BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock; Will Add Duchenne Muscular Dystrophy Products to Rare-Disease Portfolio... MORE >
- BioMarin to Attend Upcoming Investor Conferences... MORE >
- Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Credit Suisse 2014 Healthcare Conference... MORE >
- /> Click here to learn more about VIMIZIM (elosulfase alfa), including full prescribing information and boxed warning.
- /> MorquioAnswers.com is an educational site for health care professionals to learn more about Morquio A diagnosis and management.
- Morquiosity.com is designed to empower the Morquio A community through education and support.
- PKU.com is a comprehensive online resource for the PKU community.